Robert Prosecký

606 total citations
22 papers, 183 citations indexed

About

Robert Prosecký is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Robert Prosecký has authored 22 papers receiving a total of 183 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Robert Prosecký's work include Cardiac, Anesthesia and Surgical Outcomes (3 papers), Cardiovascular Function and Risk Factors (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Robert Prosecký is often cited by papers focused on Cardiac, Anesthesia and Surgical Outcomes (3 papers), Cardiovascular Function and Risk Factors (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Robert Prosecký collaborates with scholars based in Czechia, Slovakia and Spain. Robert Prosecký's co-authors include Martin Čaprnda, Peter Kružliak, Luı́s Rodrigo, Peter Kubatka, Daniel Petrovič, Katarína Gazdíková, Dietrich Büsselberg, Peter Sabaka, Marek Samec and Lenka Koklesová and has published in prestigious journals such as Scientific Reports, European Journal of Pharmacology and Biomedicine & Pharmacotherapy.

In The Last Decade

Robert Prosecký

19 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Prosecký Czechia 8 64 46 29 26 25 22 183
Yu Hashimoto Japan 10 73 1.1× 68 1.5× 19 0.7× 19 0.7× 46 1.8× 42 229
Masahiro Wanezaki Japan 8 128 2.0× 54 1.2× 14 0.5× 26 1.0× 22 0.9× 29 214
Johann Bauersachs Germany 9 113 1.8× 63 1.4× 24 0.8× 22 0.8× 38 1.5× 43 220
Weihua Zhang China 9 42 0.7× 74 1.6× 64 2.2× 12 0.5× 28 1.1× 33 209
Yingguang Shan China 9 121 1.9× 92 2.0× 16 0.6× 25 1.0× 75 3.0× 23 246
Julie Pester United States 6 117 1.8× 44 1.0× 10 0.3× 16 0.6× 32 1.3× 8 260
Yang Su China 11 104 1.6× 60 1.3× 29 1.0× 9 0.3× 17 0.7× 30 246
Philip Düsing Germany 7 71 1.1× 114 2.5× 35 1.2× 12 0.5× 53 2.1× 16 280
Sanae Saka Japan 9 47 0.7× 35 0.8× 37 1.3× 9 0.3× 27 1.1× 26 173
Quan Liu China 9 23 0.4× 84 1.8× 27 0.9× 13 0.5× 63 2.5× 45 260

Countries citing papers authored by Robert Prosecký

Since Specialization
Citations

This map shows the geographic impact of Robert Prosecký's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Prosecký with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Prosecký more than expected).

Fields of papers citing papers by Robert Prosecký

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Prosecký. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Prosecký. The network helps show where Robert Prosecký may publish in the future.

Co-authorship network of co-authors of Robert Prosecký

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Prosecký. A scholar is included among the top collaborators of Robert Prosecký based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Prosecký. Robert Prosecký is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiravský, Otakar, et al.. (2024). Sarcopenia and adipose tissue evaluation by artificial intelligence predicts the overall survival after TAVI. Scientific Reports. 14(1). 8842–8842. 4 indexed citations
2.
Mazuráková, Alena, Zuzana Solárová, Lenka Koklesová, et al.. (2023). Heat shock proteins in cancer – Known but always being rediscovered: Their perspectives in cancer immunotherapy. Advances in Medical Sciences. 68(2). 464–473. 7 indexed citations
3.
McSweeney, Kristen Renee, Laura Kate Gadanec, Peter Kubatka, et al.. (2023). Cisplatin treatment reduces contraction to angiotensin II by altering expression of angiotensin II receptors: a pilot study. Molecular and Cellular Biochemistry. 478(12). 2907–2916.
4.
Samec, Marek, Alena Mazuráková, Lenka Koklesová, et al.. (2023). Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2. European Journal of Pharmacology. 949. 175655–175655. 13 indexed citations
5.
Gadanec, Laura Kate, Kristen Renee McSweeney, Peter Kubatka, et al.. (2023). Angiotensin II constricts mouse iliac arteries: possible mechanism for aortic aneurysms. Molecular and Cellular Biochemistry. 479(2). 233–242. 3 indexed citations
6.
7.
Prosecký, Robert & Jiří Vítovec. (2023). Tirzepatid - a new hope in the treatment of obesity and a new antidiabetic drug. 37(2). 68–71.
8.
Mazuráková, Alena, Lenka Koklesová, Marek Samec, et al.. (2022). Flavonoids exert potential in the management of hypertensive disorders in pregnancy. Pregnancy Hypertension. 29. 72–85. 10 indexed citations
9.
Zagatina, A, Martin Čaprnda, Ľudovít Gašpar, et al.. (2022). Prognostic value of Doppler echocardiographic coronary flow velocity assessment at rest in elderly patients. Acta cardiologica. Supplementum. 78(4). 409–416.
10.
Samec, Marek, Alena Líšková, Lenka Koklesová, et al.. (2020). The role of plant-derived natural substances as immunomodulatory agents in carcinogenesis. Journal of Cancer Research and Clinical Oncology. 146(12). 3137–3154. 22 indexed citations
11.
12.
Jašek, Karin, Marian Grendár, Tatiana Burjanivová, et al.. (2020). Prevalence and significance of M541L single nucleotide polymorphism in the central European cohort of gastrointestinal stromal tumor patients. Journal of Cancer Research and Clinical Oncology. 147(4). 1203–1215. 2 indexed citations
13.
Čaprnda, Martin, Anthony Zulli, Haaris A. Shiwani, et al.. (2020). The therapeutic effect of B‐type natriuretic peptides in acute decompensated heart failure. Clinical and Experimental Pharmacology and Physiology. 47(7). 1120–1133. 4 indexed citations
14.
Tumanovska, Lesya V., Katarína Gazdíková, Luı́s Rodrigo, et al.. (2019). MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma. Clinical and Experimental Medicine. 19(4). 515–524. 9 indexed citations
15.
Čaprnda, Martin, Aleš Mrhar, Peter Kubatka, et al.. (2019). Impact of drugs on venous thromboembolism risk in surgical patients. European Journal of Clinical Pharmacology. 75(6). 751–767. 7 indexed citations
16.
Čaprnda, Martin, Peter Kubatka, Katarína Gazdíková, et al.. (2017). Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders. Biomedicine & Pharmacotherapy. 91. 60–69. 20 indexed citations
17.
Sabaka, Peter, Martin Čaprnda, Daniel Petrovič, et al.. (2017). Atherogenic index of plasma is positively associated with the risk of all-cause death in elderly women. Wiener klinische Wochenschrift. 129(21-22). 793–798. 34 indexed citations
18.
Vujkovac, Andreja Cokan, Martin Čaprnda, Ioana Mozoş, et al.. (2017). Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus. VASA. 46(5). 363–369. 12 indexed citations
19.
Sochor, Ondřej, Eva Králíková, Renata Cífková, et al.. (2014). Tobacco use and some characteristics of tobacco users. Preliminary results of "Kardiovize Brno 2030". Cor et Vasa. 56(2). e118–e127. 3 indexed citations
20.
Meluzı́n, Jaroslav, Jan Sitar, Robert Prosecký, et al.. (2011). The role of exercise echocardiography in the diagnostics of heart failure with normal left ventricular ejection fraction. European Journal of Echocardiography. 12(8). 591–602. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu Hashimoto Breakdown of academic impact, for papers by Masahiro Wanezaki Breakdown of academic impact, for papers by Johann Bauersachs Breakdown of academic impact, for papers by Weihua Zhang Breakdown of academic impact, for papers by Yingguang Shan Breakdown of academic impact, for papers by Julie Pester Breakdown of academic impact, for papers by Yang Su Breakdown of academic impact, for papers by Philip Düsing Breakdown of academic impact, for papers by Sanae Saka Breakdown of academic impact, for papers by Quan Liu
Rankless by CCL
2026